Antibiotics for early-onset neonatal infection: a summary of the NICE guideline 2012
Article first published online: 23 APR 2014
© 2014 Royal College of Obstetricians and Gynaecologists
The Obstetrician & Gynaecologist
Volume 16, Issue 2, pages 87–92, April 2014
How to Cite
Antibiotics for early-onset neonatal infection: a summary of the NICE guideline 2012. The Obstetrician & Gynaecologist 2014;16:87–92., , , , .
- Issue published online: 23 APR 2014
- Article first published online: 23 APR 2014
- Manuscript Accepted: 13 JAN 2014
- Manuscript Revised: 6 DEC 2013
- Manuscript Received: 5 APR 2013
- cost effectiveness;
- early-onset neonatal infection;
- group B streptococcus;
- intrapartum antibiotic prophylaxis;
- preterm rupture of membranes
- Early-onset neonatal infection (infection arising within 72 hours of birth) is an important cause of morbidity and mortality and is often caused by Streptococcus agalactiae (group B streptococcus [GBS]).
- Identifying and assessing risk factors for early-onset neonatal infection before and during labour and birth is integral to clinical management.
- Intrapartum antibiotic prophylaxis (IAP) to prevent early-onset neonatal infection is effective when given to women with particular risk factors, including maternal GBS colonisation.
- When IAP is given specifically to prevent early-onset neonatal infection with GBS the National Institute for Health and Care Excellence (NICE) recommends using benzylpenicillin.
- Alternative antibiotic regimens are appropriate for women who are allergic to penicillin or where local microbiological surveillance data indicate antibiotic resistance.
- To be aware of the risk factors for early-onset neonatal infection.
- To understand how IAP can reduce the risk of an early-onset neonatal infection.
- To know which antibiotic to use for IAP of GBS.
- How should decisions about whether to administer IAP trade off the potential benefit to the baby of preventing an early-onset neonatal infection and potential harms to the woman, such as, allergic reactions and increased medicalisation of pregnancy?
- How should decisions about the choice of antibiotics used in intrapartum prophylaxis take account of the risk of promoting antibiotic resistance?